___

• Kaynaklar 1.McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lan-cet 2003; 362: 1295-304. 2.Craig PS, McManus DP, Lightowlers MW, et al. Preventionand control of cystic echinococcosis. Lancet Infect Dis 2007;7: 385-94. 3.Brunetti E, Junghanss T. Update on cystic hydatid disease. CurrOpin Inf Dis 2009; 22: 497-502. 4.Eckert J, Deplazes P. Biological, epidemiological, and clini-cal aspects of echinococcosis, a zoonosis of increasing con-cern. Clin Microbiol Rev 2004; 17: 107-35. 5.Tappe D, Zidowitz S, Demmer P, Kern P, Barth TF, Frosch M.Three-dimensional reconstruction of Echinococcus multilocu-laris larval growth in human hepatic tissue reveals complexgrowth patterns. Am J Trop Med Hyg 2010; 82 (1): 126-27. 6.Jenkins EJ, Peregrine AS, Hill JE, et al. Detection of Euro-pean Strain of Echinococcus multilocularis in North Ameri-ca. Emerg Infect Dis 2012; 18 (6): 1010-12. 7.Ammann R, Eckert J. Cestodes: Echinococcus. GastroenterolClin N Am 1996; 25: 655–89. 8.Pawlowski Z, Eckert J, Vuitton DA, et al. Echinococcosis inhumans: clinical aspects, diagnosis and treatment. In: EckertJ, Gemmell MA, Meslin FX, Pawlowski Z, eds. WHO/OIE Ma-nual on Echinococcosis in humans and animals. Paris: Offi-ce International des Épizooties; 2001: 20-71. 9.Zhang W, McManus DP. Recent advances in the immunologyand diagnosis of echinococcosis. FEMS Immunol Med Mic-robiol 2006; 47: 24—41. 10.Carmena D, Benito A, Eraso E. The immunodiagnosis of Ec-hinococcus multilocularis infection. Clin Microbiol Infect 2007;13: 460-75. 11.Smego Jr RA, Sebanego P. Treatment options for hepatic cysticechinococcosis. Int J Infect Dis 2005; 9: 69-76. 12.Cobo F, Yarnoz C, Sesma B, et al. Albendazole plus praziquan-tel versus albendazole alone as a pre- operative treatment inintra-abdominal echinococcosis caused by Echinococcusgranulosus. Trop Med Int Health 1998; 3: 462—66. 13.Moro P, Schantz PM. Echinococcosis: a review. Int J InfectDis 2009; 13 (2): 125-33.14.Khuroo MS, Dar MY, Yattoo GN, Shah AH, Jeelani SG. Per-cutaneous drainage versus albendazole therapy in hepatic hyda-tidosis: a perspective, randomized study. Gastroenterology1993; 104: 1452-59. 15.Koch S, Bresson-Hadni S, Miguet JP, et al. Experience of li-ver transplantation for incurable alveolar echinococcosis: a45-case European collaborative report. Transplantation2003; 75: 856—63. 16.Lightowlers M, Jensen O, Fernandez E, et al. Vaccination tri-als in Australia and Argentina confirm the effectiveness of theEG95 hydatid vaccine in sheep. Int J Parasitol 1999; 29: 531–34. 17.Zhang W, Zhang Z, Shi B, et al. Vaccination of dogs againstEchinococcus granulosus, the cause of cystic hydatid disea-se in humans. J Infect Dis 2006; 194: 966—74. 18.Eckert J, Deplazes P. Biological, epidemiological, and clini-cal aspects of echinococcosis, a zoonosis of increasing con-cern. Clin Microbiol Rev 2004; 17: 107—35.